Electron beam CT (computed tomography) "cheaper" than exercise test:
This article was originally published in Clinica
In certain patients electron beam CT could offer cost benefits over exercise treadmill testing as an initial test for coronary artery disease, US researchers have concluded. Reporting in the February 1 edition of the American Journal of Cardiology, Dr Paolo Raggi and colleagues said that in 207 patients with a low to intermediate probability of coronary artery disease, EBCT provided savings of 45% to 65%. The researchers said the lower sensitivity of EBCT compared with nuclear imaging for obstructive disease and higher sensitivity for subclinical atherosclerotic disease meant that unnecessary follow-up angiography could be avoided more often.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.